Flagship Pioneering Inc. Axcella Health Inc. Transaction History

Flagship Pioneering Inc.

  • $589 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.16 - $1.1 $1.66 Million - $11.4 Million
10,383,760 Added 55.03%
29,251,545 $9.65 Million
Q1 2022

May 16, 2022
BUY
$1.58 - $2.82 $9.98 Million - $17.8 Million
6,319,371 Added 50.36%
18,867,785 $48.5 Million
Q2 2020

Aug 13, 2020
BUY
$2.94 - $7.7 $11.2 Million - $29.3 Million
3,800,000 Added 43.44%
12,548,414 $69.4 Million
Q2 2019

Aug 13, 2019
BUY
$8.51 - $14.95 $74.4 Million - $131 Million
8,748,414 New
8,748,414 $81.4 Million

Others Institutions Holding AXLA

# of Institutions
2
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About Axcella Health Inc.

AXLA Quotes by TradingView
  • Ticker AXLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,500,896
  • Description
  • Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...
More about AXLA
Track This Portfolio

Track Flagship Pioneering Inc. Portfolio

Follow Flagship Pioneering Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Pioneering Inc., based on Form 13F filings with the SEC.

News

Stay updated on Flagship Pioneering Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email